Maryland Injury Lawyers Note Heparin Maker Has Local Ties
Article posted on:04/23/2008
Maryland personal injury lawyers are preparing for a potential class action law suit against a Maryland firm which owns the majority of Wisconsin based Scientific Protein Laboratories, Ltd., a Wisconsin-based company.
According to The Daily Record, the FDA sent Scientific Protein Laboratories a warning letter that its plant in China is believed to be producing the contaminated heparin. American Capital Strategies, located in Bethesda Maryland, owns 90% of the Wisconsin-based company. A Maryland class action law suit may be ripe against the Maryland based company based on deaths and injuries associated with the contaminated heparin. Maryland personal injury lawyers Silverman, Thompson, Slutkin & White have served as local counsel for a major class action in the past and are currently accepting new clients who have been injured by the tainted heparin.
Heparin is used in dialysis and is also used to prevent clotting in catheters, which 25 percent of dialysis patients have to use for treatment. The drug is also commonly used in heart bypass surgery. As an anticoagulant, Heparin can be used to reduced the risk of blood clots before surgery.
Other risks associated with Heparin use are bleeding episodes that are difficult to control. Additionally, even if after a patient is taken off of Heparin they typically can still have bleeding episodes for weeks thereafter. Other common, but serious side effects, that can occur with Heparin use include, but are not limited to: sudden numbness or weakness on one side of the body, sudden severe headache, confusion, problems with vision, speech or balance, chest pain, sudden cough, wheezing, rapid breathing, fast heart rate, pain swelling, warmth or redness in legs, trouble breathing or fever, chills, runny nose or watery eyes. Patients should also be sure to tell their doctors if they have high blood pressure, heart infections or bleeding disorders because Heparin can impact these conditions adversely.